Model
Edge
Lineage Cell Therapeutics
0001325697
Filing Type
4
Filing Date
7/2/2024
Updated
7/3/24, 3:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership